Odonate Therapeutics, Inc.

ODTC · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income$7$43-$68-$126
Dep. & Amort.$0$0$1$0
Deferred Tax$2-$33$0$0
Stock-Based Comp.$0$0$4$10
Change in WC-$1-$9-$15$2
Other Non-Cash$0$1$2$0
Operating Cash Flow$9$2-$76-$113
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$17-$58$0$0
Inv. Sales/Matur.$37$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$20-$58-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$1$87
Stock Repurch.$0-$2-$14$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0$3
Financing Cash Flow-$0-$2-$13$90
Forex Effect$0$0$0$0
Net Chg. in Cash$29-$58-$88-$23
Supplemental Information
Beg. Cash$11$69$157$181
End Cash$40$11$69$158
Free Cash Flow$9$2-$76-$114